Home > Boards > US Listed > Biotechs > Exact Sciences (EXAS)

*****Very good article IMHO.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
TREND1 Member Profile
Member Level 
Followed By 407
Posts 54,558
Boards Moderated 38
Alias Born 12/16/01
160x600 placeholder
Annual Report of Employee Stock Plans (11-k) Edgar (US Regulatory) - 6/30/2020 9:19:00 AM
Oncotype DX Genomic Prostate Score® Result Shows for the First Time the Value of the Test to Guide Treatment Plans for Unfav... PR Newswire (US) - 6/16/2020 8:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(7) (424b7) Edgar (US Regulatory) - 6/2/2020 6:08:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/2/2020 6:01:05 AM
Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr) Edgar (US Regulatory) - 6/1/2020 4:11:07 PM
Exact Sciences Showcases Continued Progress in Cancer Diagnostics at ASCO 2020 PR Newswire (US) - 5/29/2020 8:00:00 AM
Exact Sciences to participate in June investor conferences PR Newswire (US) - 5/26/2020 6:00:00 AM
New Oncotype DX® Real-world Evidence Shows for the First Time the Practice-changing Impact of TAILORx Results PR Newswire (US) - 5/14/2020 6:00:00 AM
New Oncotype DX® Real-world Evidence Shows for the First Time the Practice-changing Impact of TAILORx Results PR Newswire (US) - 5/14/2020 6:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/6/2020 4:11:26 PM
Exact Sciences Announces First Quarter 2020 Results PR Newswire (US) - 5/6/2020 4:05:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/6/2020 4:04:20 PM
New Model Shared at Digestive Disease Week (DDW) Demonstrates the Value of Cologuard® When Using Real-World Adherence Rates ... PR Newswire (US) - 5/5/2020 10:30:00 AM
Exact Sciences to participate in May investor conference PR Newswire (US) - 5/4/2020 6:00:00 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/29/2020 4:11:47 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/29/2020 4:10:37 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/24/2020 4:51:53 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 4/24/2020 4:48:25 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/24/2020 8:13:15 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/22/2020 4:19:39 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 4/22/2020 4:15:20 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/21/2020 4:33:30 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 4/17/2020 4:30:30 PM
Exact Sciences schedules first-quarter 2020 earnings call PR Newswire (US) - 4/8/2020 6:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/6/2020 4:41:56 PM
TREND1 Member Level  Tuesday, 11/21/17 11:37:14 AM
Re: DewDiligence post# 549
Post # of 609 
*****Very good article IMHO.

11/21 Exact Sciences, We Bid You Farewell


•EXAS share price more than quadrupled since the beginning of 2017. Time to take profit.

•EXAS has generated losses since its inception and expects to continue to incur losses in the near future.

•EXAS is currently valued at more than 27 times price-to-2017-sales, rather pricey for the molecular diagnostics industry sector.



https://seekingalpha.com/article/4126796-sold-cologuard-maker-exact-sciences?auth_param=1vat:1d18h27:bb41b36a79b3544547eed9f8b9a0cbb6&uprof=51#alt2


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist